Kelley ME - Search Results

1

Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation.

Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH, Malison R, Rao PA, Kobayashi K, Nagatsu T, Gelernter J. Cubells JF, et al. Among authors: kelley me. Hum Genet. 1998 May;102(5):533-40. doi: 10.1007/s004390050736. Hum Genet. 1998. PMID: 9654201

2

CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures.

van Kammen DP, Kelley ME, Gilbertson MW, Gurklis J, O'Connor DT. van Kammen DP, et al. Among authors: kelley me. Am J Psychiatry. 1994 Mar;151(3):372-8. doi: 10.1176/ajp.151.3.372. Am J Psychiatry. 1994. PMID: 8109645

3

Empirical validation of primary negative symptoms: independence from effects of medication and psychosis.

Kelley ME, van Kammen DP, Allen DN. Kelley ME, et al. Am J Psychiatry. 1999 Mar;156(3):406-11. doi: 10.1176/ajp.156.3.406. Am J Psychiatry. 1999. PMID: 10080556

4

Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia.

Kelley ME, Yao JK, van Kammen DP. Kelley ME, et al. Neuropsychopharmacology. 1999 Jun;20(6):603-11. doi: 10.1016/S0893-133X(98)00094-3. Neuropsychopharmacology. 1999. PMID: 10327429

5

GABA and brain abnormalities in schizophrenia.

van Kammen DP, Petty F, Kelley ME, Kramer GL, Barry EJ, Yao JK, Gurklis JA, Peters JL. van Kammen DP, et al. Among authors: kelley me. Psychiatry Res. 1998 Apr 10;82(1):25-35. doi: 10.1016/s0925-4927(98)00006-7. Psychiatry Res. 1998. PMID: 9645548

6

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status.

McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME, Yao J, Peters JL. McAllister CG, et al. Among authors: kelley me. Am J Psychiatry. 1995 Sep;152(9):1291-7. doi: 10.1176/ajp.152.9.1291. Am J Psychiatry. 1995. PMID: 7653683

7

Dopamine and norepinephrine activity in schizophrenia. An integrative perspective.

van Kammen DP, Kelley M. van Kammen DP, et al. Schizophr Res. 1991 Mar-Apr;4(2):173-91. doi: 10.1016/0920-9964(91)90032-m. Schizophr Res. 1991. PMID: 2039760 Review.

8

Elevated cerebrospinal fluid SNAP-25 in schizophrenia.

Thompson PM, Kelley M, Yao J, Tsai G, van Kammen DP. Thompson PM, et al. Biol Psychiatry. 2003 Jun 15;53(12):1132-7. doi: 10.1016/s0006-3223(02)01599-8. Biol Psychiatry. 2003. PMID: 12814864

9

Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.

Beuger M, van Kammen DP, Kelley ME, Yao J. Beuger M, et al. Among authors: kelley me. Neuropsychopharmacology. 1996 Jul;15(1):75-86. doi: 10.1016/0893-133X(95)00158-A. Neuropsychopharmacology. 1996. PMID: 8797194

10

Utility of WAIS-R short forms in schizophrenia.

Allen DN, Huegel SG, Gurklis JA Jr, Kelley ME, Barry EJ, van Kammen DP. Allen DN, et al. Among authors: kelley me. Schizophr Res. 1997 Aug 29;26(2-3):163-72. doi: 10.1016/s0920-9964(97)00052-2. Schizophr Res. 1997. PMID: 9323347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page